Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
about
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesTherapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromesChronic neutrophilic leukemia: a clinical perspectiveChronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and managementCIViC databaseOncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CMLEvaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literatureThe Basic Biology of PP2A in Hematologic Cells and MalignanciesMutational landscape and significance across 12 major cancer typesIntegrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumorsCEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data.Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseasesCAPRI: efficient inference of cancer progression models from cross-sectional data.ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.Prioritization of neurodevelopmental disease genes by discovery of new mutations.CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.From the Biology of PP2A to the PADs for Therapy of Hematologic MalignanciesRefining analyses of copy number variation identifies specific genes associated with developmental delayCrizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.Sample processing obscures cancer-specific alterations in leukemic transcriptomes.Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemiaSubclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaTherapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid LeukemiaThe molecular basis of myeloid malignancies.Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.Inferring tree causal models of cancer progression with probability raising.Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaSETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent CSF3R and SETBP1 mutations: A case report.Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia developmentBleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
P2860
Q24596715-6E259A8A-395D-4299-9894-B5284C988680Q26752940-172F2E7A-6C20-4891-BF96-767EE1855725Q26781167-5C607D64-3116-41F2-8B45-5B079D3EABADQ27009366-70D7FF90-FA87-4EF5-B02E-473FDD709006Q27612411-6CB2A1EA-5190-48E8-BF63-B638DF969F66Q27852275-62C2E5BA-EC50-48AE-B2A1-5144EAF94884Q28083489-270645A5-E55B-4517-8DF6-C3675F14F5CBQ28088697-6C93A837-73BF-4FDB-98F2-1FEB909AEB9DQ28300353-66CD84A8-53B4-4ECB-9BE6-557E06F64C1AQ28602517-5B223658-138B-406E-8B52-91963E8A9F4BQ30677391-1A3A98E5-3249-43D5-AA9B-ECF9D758AE5FQ30749239-8A34A100-D6E8-41CB-8C0E-DAA2E37D7410Q30951310-5A46B7C3-3669-4487-972C-D8504039820BQ33421772-35CFB7C8-BEB1-4E08-A6A8-2B7DA2E1206DQ33591367-360BCE9E-BA41-404C-9634-82E13FBE58C2Q33794297-D0169306-C599-4C16-A451-D04630A081EAQ33830995-3BDF62D3-13F4-4147-A05D-6841C0A58597Q33909621-183F82DA-9A27-46E3-BE38-A03101E02CB6Q34043449-80023E50-24DD-4E03-8638-3AF04A0A8801Q34254472-399B95E8-753D-42A6-9EF0-1701F8A6DC4CQ34401878-1D212A86-CA66-490B-A224-1E4A314307EFQ34601323-DE142344-B057-458A-9C45-A0CB3C4F1548Q34667249-3E4218F6-02BE-4830-BBE1-2D3483426921Q34700714-ED0C9848-F659-4676-B017-DA8276638992Q34749589-9E465F4A-64A2-45BB-8E96-72748B8992A7Q34974064-BCF74FF9-A511-49E4-B717-7CB88EDC948CQ35037262-203CA85B-B779-476B-98ED-0BFC3281E1F8Q35103708-14CACF31-EB2B-42AA-8887-E60B8DA65221Q35252614-90991DC8-22F2-46EA-88AE-528C187340AFQ35316887-AF3BDCCE-52E1-4DFA-AC47-A5CE0A49DD97Q35610140-C3D96DC3-DDD3-4820-80D7-2CF51C54B010Q35654081-FA73171A-61F3-44E8-89DB-0598D30B6524Q35849733-C286B8AB-08DC-45C2-84D6-A970F3457D10Q35944494-A09711D9-BF9F-416C-89A1-0CDD31C9CDECQ36222022-ED5C65A5-272F-4A04-A545-5C07D0FBB21FQ36270003-4DD09BE6-D397-474D-8838-AC6EF702F6C8Q36323864-AEE8909C-58D1-41FA-B483-A718000A067DQ36437137-541CA1DA-6132-4868-BCBF-274EA29DADE6Q36654317-8A3D8585-2878-4650-A8FC-FE568318E6EFQ36693223-DCADFA55-EE74-4B0A-83EE-28D545BA9C7D
P2860
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@ast
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@en
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
@nl
type
label
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@ast
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@en
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
@nl
altLabel
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@en
prefLabel
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@ast
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@en
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
@en
P2093
Alessandra Pirola
Andrew J Chase
Carla Donadoni
Dong-Wook Kim
Enrico Maria Pogliani
Fabio Rossi
Giuseppe Gaipa
Graham R Bignell
Greta P De Martini
Hyun Gyung Jang
P2860
P2888
P3181
P356
10.1038/NG.2495
P407
P50
P577
2013-01-01T00:00:00Z
P5875
P6179
1017039547